医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ABLIC Inc. Launches the S-85M0A Series of Ultra-High Efficiency Step-Down Switching Regulators in the Industry’s Most Compact(*) Size

2018年08月20日 PM04:55
このエントリーをはてなブックマークに追加


 

CHIBA, Japan

ABLIC Inc. (hereinafter “ABLIC”), a semiconductor manufacturer, today launched the S-85M0A Series of ultra-high efficiency step-down switching regulators for wearable and IoT devices.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180820005184/en/

WLP-6L (Graphic: Business Wire)

WLP-6L (Graphic: Business Wire)

The IC in the step-down switching regulator repeatedly turns a switch on and off. The resulting charges generated in the coil are stored in a capacitor and used to convert the battery voltage. It converts the 3.6V battery voltage (from a lithium-ion battery) to the proper voltage (1.8V or 2.5V) for mobile devices such as a smart phone.

The S-85M0A Series of ultra-high efficiency step-down switching regulators is housed in the WLP-6L, the industry’s most compact package (1.25*0.79*t0.55mm), and achieves an ultra-low current consumption of 260nA, the industry’s top-class current consumption. It reduces the footprint of the mounting area and the surrounding components by 52% compared to our previous product.
(*) Based on our research as of July 2018.

Major Features
1. Housed in ultra-compact WLP-6L (1.25*0.79*t0.55mm) package
2. Reduces battery drain for wearable and IoT devices during standby
3. Low EMI

Application Examples

– Wearable devices     – IoT devices     – Bluetooth devices
– Health care devices – Smart meters
– Low-power wireless sensor network devices
 

Datasheet URL:
S-85M0A Series
https://www.ablic.com/en/doc/datasheet/switching_regulator/S85M0A_E.pdf

The S-85M1A Series, a product with a different output current (200mA), was released together with the S-85M0A Series.
https://www.ablic.com/en/doc/datasheet/switching_regulator/S85M1A_E.pdf

Web site:
https://www.ablic.com/en/semicon/

View source version on businesswire.com: https://www.businesswire.com/news/home/20180820005184/en/

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma
  • MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil
  • SanBio: Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623
  • SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623
  • 首例神经母细胞瘤患者成功接受采用自然杀伤T细胞(CAR-NKT)的创新型CAR疗法